SMS Pharmaceuticals successfully completes USFDA inspection at Hyderabad facility

20 Nov 2017 Evaluate

SMS Pharmaceuticals has successfully completed its fifth US Food and Drug Administration (US FDA) inspection for its manufacturing facility Unit-II located at Plot No.24 & 24B and 36 & 37, S V Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad in state of Telangana. There were no ‘Form 483’ observations issued during the inspection.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.



SMS Pharmaceuticals Share Price

177.95 -0.70 (-0.39%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.